Migraine Drugs Market Size 2023, Forecast By 2032

The Business Research Company’s Migraine Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Migraine Global Market Report 2023 evaluates migraine market size, growth rate, drivers, trends, and major companies.

The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=12919&type=smp

The global migraine market is expected to grow from $1.87 billion in 2023 to $1.93 billion in 2024 at a compound annual growth rate (CAGR) of 3.1%. The growth in the historic period can be attributed to increasing prevalence of migraines, growing awareness about migraine treatment, government initiatives, increasing prevalence of alcohol consumption, shifts in lifestyle. The migraine market size is expected to see steady growth in the next few years. It will grow to $2.15 billion in 2028 at a compound annual growth rate (CAGR) of 2.8%.

The increase in the prevalence of migraine is expected to propel the growth of the migraine market going forward. A migraine is a type of headache that typically affects one side of the brain and produces excruciating throbbing pain or a pulsing sensation. Migraine treatment offers numerous benefits for managing and alleviating the symptoms of migraines by relieving the pain, with improved functionality, reduced frequency and severity, enhanced productivity and quality of life of the people suffering from migraine. For instance, in January 2023, according to Nature Reviews Neurology, a UK-based journal website, globally, the current estimated prevalence of migraine is 14- 15%, accounting for 4.9% of the global population ill health quantified in years (actual year) with disability (YLDs). Therefore, the increase in the prevalence of migraine drives the migraine market.

Get More Information On The Migraine Market Report:

https://www.thebusinessresearchcompany.com/report/migraine-global-market-report

The migraine market segments in the report are:

1) By Type: Episodic, Chronic

2) By Treatment: Preventive, Abortive

3) By Drug Class: Triptans, Ergots, Other Drug Classes

The table of contents in TBRC’s migraine market report includes:

1. Executive Summary
2. Migraine Market Characteristics
3. Migraine Market Trends And Strategies
4. Migraine Market – Macro Economic Scenario
5. Global Migraine Market Size and Growth

.

.

.

32. Global Migraine Market Competitive Benchmarking
33. Global Migraine Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Migraine Market
35. Migraine Market Future Outlook and Potential Analysis
36. Appendix

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model